These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1329293)
1. Pharmacological effects of drug conjugates: is morphine 6-glucuronide an exception? Mulder GJ Trends Pharmacol Sci; 1992 Aug; 13(8):302-4. PubMed ID: 1329293 [No Abstract] [Full Text] [Related]
2. Morphine-6-glucuronide, a potent mu agonist. Pasternak GW; Bodnar RJ; Clark JA; Inturrisi CE Life Sci; 1987 Dec; 41(26):2845-9. PubMed ID: 2826951 [TBL] [Abstract][Full Text] [Related]
3. Physicochemical and Pharmacological Characterization of Permanently Charged Opioids. Mazak K; Noszal B; Hosztafi S Curr Med Chem; 2017; 24(33):3633-3648. PubMed ID: 28685673 [TBL] [Abstract][Full Text] [Related]
4. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine. Francés B; Gout R; Campistron G; Panconi E; Cros J Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808 [TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of an opioid receptor probe: mode of binding of S-activated (-)-6 beta-sulfhydryldihydromorphine with the SH group in the mu-opioid receptor. Kanematsu K; Naito R; Shimohigashi Y; Ohno M; Ogasawara T; Kurono M; Yagi K Chem Pharm Bull (Tokyo); 1990 May; 38(5):1438-40. PubMed ID: 1975519 [No Abstract] [Full Text] [Related]
6. Morphine-6-glucuronide and morphine: mu-opioid receptor binding and effects on dopamine-sensitive adenylate cyclase in striatum. Christensen CB; Mørk A; Geisler A Pharmacol Toxicol; 1991 Nov; 69(5):396-8. PubMed ID: 1666432 [No Abstract] [Full Text] [Related]
7. Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors. Grung M; Skurtveit S; Aasmundstad TA; Handal M; Alkana RL; Mørland J Pharmacol Toxicol; 1998 Jan; 82(1):3-10. PubMed ID: 9527644 [TBL] [Abstract][Full Text] [Related]
8. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. Frances B; Gout R; Monsarrat B; Cros J; Zajac JM J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. Bartlett SE; Dodd PR; Smith MT Pharmacol Toxicol; 1994 Aug; 75(2):73-81. PubMed ID: 7971741 [TBL] [Abstract][Full Text] [Related]
10. Morphine-6-glucuronide has high affinity for the opioid receptor. Christensen CB; Jørgensen LN Pharmacol Toxicol; 1987 Jan; 60(1):75-6. PubMed ID: 3031640 [No Abstract] [Full Text] [Related]
11. 3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties. Wentland MP; Lou R; Dehnhardt CM; Duan W; Cohen DJ; Bidlack JM Bioorg Med Chem Lett; 2001 Jul; 11(13):1717-21. PubMed ID: 11425545 [TBL] [Abstract][Full Text] [Related]
12. Morphine-6-glucuronide: actions and mechanisms. Kilpatrick GJ; Smith TW Med Res Rev; 2005 Sep; 25(5):521-44. PubMed ID: 15952175 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro biological evaluation of a carbon glycoside analogue of morphine-6-glucuronide. MacDougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR Bioorg Med Chem Lett; 2005 Mar; 15(6):1583-6. PubMed ID: 15745801 [TBL] [Abstract][Full Text] [Related]
17. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes. Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575 [TBL] [Abstract][Full Text] [Related]
18. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Abbott FV; Palmour RM Life Sci; 1988; 43(21):1685-95. PubMed ID: 2848167 [TBL] [Abstract][Full Text] [Related]
19. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia. Rossi GC; Brown GP; Leventhal L; Yang K; Pasternak GW Neurosci Lett; 1996 Sep; 216(1):1-4. PubMed ID: 8892377 [TBL] [Abstract][Full Text] [Related]
20. [Ligand recognition in the opioid receptors by modeling methods and the design of opioids]. Kanematsu K Yakugaku Zasshi; 1998 Jan; 118(1):1-18. PubMed ID: 9484038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]